Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.91
+0.09730.29%
Post-market: 33.80-0.1064-0.31%16:10 EDT
Volume:365
Turnover:12.38K
Market Cap:13.56M
PE:- -
High:33.91
Open:33.80
Low:33.80
Close:33.81
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.21
T/O Rate:0.09%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Reuters
·
4 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
4 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
5 hours ago

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
5 hours ago

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
6 hours ago

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Yesterday

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.
·
Yesterday

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Yesterday

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS
·
Yesterday

Satellos to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Yesterday

Immunic Appoints Chitrang Davé as Chief Data and Digital Officer

Reuters
·
Yesterday

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

TIPRANKS
·
Yesterday

EDX Medical confirms total voting rights at over 431 million shares

TIPRANKS
·
Yesterday

Zhifei Biological's Freeze-Dried Rabies Vaccine Candidate Receives Clinical Trial Application Acceptance

Stock News
·
Yesterday

Centergate Subsidiary Gains Clinical Trial Clearance for Methylphenidate Prolonged-Release Chewable Tablet

Stock News
·
Yesterday

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Stock News
·
Yesterday

Celemics inks major U.S. diagnostics licensing and supply deal

TIPRANKS
·
Yesterday

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

GlobeNewswire
·
Yesterday

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
Yesterday